Capecitabine With Digoxin for Metastatic Breast Cancer

NCT01887288 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped PI Leaving Site

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Digoxin

Sponsor

Western Regional Medical Center